Suchen
BCPE Perseus Investor Ord Shs (Proposed)
KLRAZur Watchlist hinzufügen
18.100USD
-0.450-2.43%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
2.24BMarktkapitalisierung
--KGV TTM
mehr Informationen über BCPE Perseus Investor Ord Shs (Proposed) Unternehmen
Kailera Therapeutics Inc is a United States-based company. The Company is a clinical-stage biopharmaceutical company developing a broad and advanced therapeutic pipeline that is poised to deliver differentiated treatment options for obesity and related conditions. Its pipeline consists of clinical- and preclinical-stage programs with injectable peptides, oral peptides, and an oral small molecule.
BCPE Perseus Investor Ord Shs (Proposed) Informationen
BörsenkürzelKLRA
Name des UnternehmensKailera Therapeutics Inc
IPO-datumApr 17, 2026
CEORenaud (Ron)
Anzahl der mitarbeiter- -
WertpapierartOrdinary Share
Geschäftsjahresende- -
Addresse180 Third Ave
StadtWALTHAM
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl02451
Telefon15084409475
Websitehttps://www.kailera.com
BörsenkürzelKLRA
IPO-datumApr 17, 2026
CEORenaud (Ron)
Führungskräfte von BCPE Perseus Investor Ord Shs (Proposed)
Name
Name/Position
Position
Aktienbesitz
Veränderung
,
,
--
--
Mr. Ron Renaud
Mr. Ron Renaud
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Paul Burgess
Mr. Paul Burgess
Chief Operating Officer, Chief Business Officer
Chief Operating Officer, Chief Business Officer
--
--
Ms. Paula Cloghessy
Ms. Paula Cloghessy
Chief People Officer
Chief People Officer
--
--
Mr. Scott M. Akamine, J.D.
Mr. Scott M. Akamine, J.D.
Chief Legal Officer, Secretary
Chief Legal Officer, Secretary
--
--
Ms. Jamie Coleman
Ms. Jamie Coleman
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Douglas W. Pagan
Mr. Douglas W. Pagan
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Scott Wasserman, M.D.
Dr. Scott Wasserman, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. John F. Milligan, Ph.D.
Dr. John F. Milligan, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Franklin K. (Frank) Clyburn, Jr.
Mr. Franklin K. (Frank) Clyburn, Jr.
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
,
,
--
--
Mr. Ron Renaud
Mr. Ron Renaud
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Paul Burgess
Mr. Paul Burgess
Chief Operating Officer, Chief Business Officer
Chief Operating Officer, Chief Business Officer
--
--
Ms. Paula Cloghessy
Ms. Paula Cloghessy
Chief People Officer
Chief People Officer
--
--
Mr. Scott M. Akamine, J.D.
Mr. Scott M. Akamine, J.D.
Chief Legal Officer, Secretary
Chief Legal Officer, Secretary
--
--
Ms. Jamie Coleman
Ms. Jamie Coleman
Chief Commercial Officer
Chief Commercial Officer
--
--
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von BCPE Perseus Investor Ord Shs (Proposed)?
Die fünf größten Anteilseigner von BCPE Perseus Investor Ord Shs (Proposed) sind: ,